Stroke, a leading cause of mortality and disability worldwide, often presents a diagnostic challenge due to its variable presentation. Early recognition and management are pivotal in improving patient outcomes. This article provides a concise guide for healthcare professionals on identifying early signs of stroke and implementing appropriate interventions.
Early recognition of stroke hinges on the acronym 'FAST' - Face drooping, Arm weakness, Speech difficulty, and Time to call emergency services. However, other subtle signs such as sudden confusion, severe headache, dizziness, or vision changes may also indicate a stroke. High clinical suspicion and rapid neurological assessment are critical in these situations.
Once a stroke is suspected, immediate diagnostic evaluation should be initiated. This includes neuroimaging, preferably with a noncontrast CT scan to rule out hemorrhage. Further tests, like MRI or angiography, may be required depending on clinical presentation and initial findings.
Acute stroke management involves a multidisciplinary approach. For ischemic strokes, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) is the treatment of choice if administered within 4.5 hours of symptom onset. In certain cases, endovascular procedures such as thrombectomy may be considered. Hemorrhagic strokes, on the other hand, may necessitate surgical intervention.
Post-stroke care is equally important and includes secondary prevention measures like controlling blood pressure, managing diabetes, and promoting a healthy lifestyle. Rehabilitation involving physical, occupational, and speech therapy plays a crucial role in improving functional outcomes and quality of life.
Stroke recognition and management require a well-coordinated, rapid response from the healthcare team. By staying abreast of the latest guidelines and maintaining a high index of suspicion, healthcare professionals can significantly impact stroke outcomes, reducing morbidity and mortality.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation